XTL Biopharmaceuticals : Immediate Report of Meeting : vimar

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549


FORM 6-K


Report of...

Related Keywords

United States , Metsada , Hadarom , Israel , Tel Aviv , Ramat Gan , Washington , American , Israeli , Shlomo Shalev , Doron Turgeman , Yair Redl , Somekh Chaikin , Ronen Kantor , Bnei Brak , Alexander Rabinovitch , Biopharmaceuticals Ltd , Israeli Securities Authority , Company Meeting , Securities Exchange , Company Form , American Depositary Shares Of The Company , Israel Companies Regulations Proof Of Ownership , Commission File Number , Israeli Companies Law , Audit Committee , Tel Aviv Stock Exchange , Companies Law , Foreign Private Issuer Pursuant , Securities Exchange Act , Extraordinary General Meeting , Doron Tikotzky Kantor Gutman , Amit Gross , Proxy Statement , Proxy Card , Voting Instruction Card , American Depositary Shares , Instruction Card , American Depositary Share , Israel Time , Certified Public Accountants , Directors Qualification , Social Proxy , Chief Executive Officer , Tal Klinger , Annual Meeting , Israel Companies Regulations , General Meetings , Gurion Street , Chief Executive , American Depository Shares , Deposit Agreement , New York Mellon , Record Shareholders , Deferred Meeting , Beach Proposal ,